Low dose tubulin-binding drugs rescue peroxisome trafficking deficit in patient-derived stem cells in Hereditary Spastic Paraplegia

Biology Open

Volumn 3, Issue 6, 2014, Pages 494-502

  Fan, Yongjun ^a   Wali, Gautam ^a   Sutharsan, Ratneswary ^a   Bellette, Bernadette ^a   Crane, Denis I ^a   Carolyn, M ^b   Mackay Sim, Sue Alan ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84979041812     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20147641     Document Type: Article

References (38)

1. Abrahamsen, G., Fan, Y., Matigian, N., Wali, G., Bellette, B., Sutharsan, R., Raju, J., Wood, S. A., Veivers, D., Sue, C. M. et al. (2013). A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations. Dis. Model. Mech. 6, 489-502.
2. Altmann, K. H., Wartmann, M. and O'Reilly, T. (2000). Epothilones and related structures - a new class of microtubule inhibitors with potent in vivo antitumor activity. Biochim. Biophys. Acta 1470, M79-M91.
3. Amos, L. A. (2011). What tubulin drugs tell us about microtubule structure and dynamics. Semin. Cell Dev. Biol. 22, 916-926.
4. Aneja, R., Dhiman, N., Idnani, J., Awasthi, A., Arora, S. K., Chandra, R. and Joshi, H. C. (2007). Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. Cancer Chemother. Pharmacol. 60, 831-839.
5. Axiak-Bechtel, S. M., Kumar, S. R., Dank, K. K., Clarkson, N. A., Selting, K. A., Bryan, J. N., Rosol, T. J., Espinosa, J. and Decedue, C. J. (2013). Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines. Invest. New Drugs 31, 1609-1615.
6. Baas, P. W., Slaughter, T., Brown, A. and Black, M. M. (1991). Microtubule dynamics in axons and dendrites. J. Neurosci. Res. 30, 134-153.
7. Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O., Koupal, L., Liesch, J., Goetz, M., Lazarides, E. and Woods, C. M. (1995). Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55, 2325-2333.
8. Brunden, K. R., Zhang, B., Carroll, J., Yao, Y., Potuzak, J. S., Hogan, A. M., Iba, M., James, M. J., Xie, S. X., Ballatore, C. et al. (2010). Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 30, 13861-13866.
9. Brunden, K. R., Yao, Y., Potuzak, J. S., Ferrer, N. I., Ballatore, C., James, M. J., Hogan, A. M., Trojanowski, J. Q., Smith, A. B. and III and Lee, V. M. (2011). The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies. Pharmacol. Res. 63, 341-351.
10. Bulinski, J. C. (2007). Microtubule modification: acetylation speeds anterograde traffic flow. Curr. Biol. 17, R18-R20.
11. Cai, D., McEwen, D. P., Martens, J. R., Meyhofer, E. and Verhey, K. J. (2009). Single molecule imaging reveals differences in microtubule track selection between Kinesin motors. PLoS Biol. 7, e1000216.
12. Checchi, P. M., Nettles, J. H., Zhou, J., Snyder, J. P. and Joshi, H. C. (2003). Microtubule-interacting drugs for cancer treatment. Trends Pharmacol. Sci. 24, 361-365.
13. Chen, S., Owens, G. C., Makarenkova, H. and Edelman, D. B. (2010). HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS ONE 5, e10848.
14. Deluca, G. C., Ebers, G. C. and Esiri, M. M. (2004). The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol. Appl. Neurobiol. 30, 576-584.
15. Denton, K. R., Lei, L., Grenier, J., Rodionov, V., Blackstone, C. and Li, X. J. (2014). Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells 32, 414-423.
16. Duning, T., Warnecke, T., Schirmacher, A., Schiffbauer, H., Lohmann, H., Mohammadi, S., Young, P. and Deppe, M. (2010). Specific pattern of early white-matter changes in pure hereditary spastic paraplegia. Mov. Disord. 25, 1986-1992.
17. Fassier, C., Tarrade, A., Peris, L., Courageot, S., Mailly, P., Dalard, C., Delga, S., Roblot, N., Lefèvre, J., Job, D. et al. (2013). Microtubule-targeting drugs rescue axonal swellings in cortical neurons from spastin knockout mice. Dis. Model. Mech. 6, 72-83.
18. Gidding, C. E., Kellie, S. J., Kamps, W. A. and de Graaf, S. S. (1999). Vincristine revisited. Crit. Rev. Oncol. Hematol. 29, 267-287.
19. Gigant, B., Wang, C., Ravelli, R. B., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A. and Knossow, M. (2005). Structural basis for the regulation of tubulin by vinblastine. Nature 435, 519-522.
20. Janke, C. and Kneussel, M. (2010). Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci. 33, 362-372.
21. Jhaveri, N., Cho, H., Torres, S., Wang, W., Schönthal, A. H., Petasis, N. A., Louie, S. G., Hofman, F. M. and Chen, T. C. (2011). Noscapine inhibits tumor growth in TMZ-resistant gliomas. Cancer Lett. 312, 245-252.
22. Kan, R., Yurttas, P., Kim, B., Jin, M., Wo, L., Lee, B., Gosden, R. and Coonrod, S. A. (2011). Regulation of mouse oocyte microtubule and organelle dynamics by PADI6 and the cytoplasmic lattices. Dev. Biol. 350, 311-322.
23. Kasher, P. R., De Vos, K. J., Wharton, S. B., Manser, C., Bennett, E. J., Bingley, M., Wood, J. D., Milner, R., McDermott, C. J., Miller, C. C. et al. (2009). Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. J. Neurochem. 110, 34-44.
24. Mackay-Sim, A. (2012). Concise review: Patient-derived olfactory stem cells: new models for brain diseases. Stem Cells 30, 2361-2365.
25. Mackay-Sim, A. (2013). Patient-derived stem cells: pathways to drug discovery for brain diseases. Front Cell Neurosci. 7, 29.
26. Massaad, C. and Klann, E. (2011). Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid. Redox. Signal. 14, 2013-2054.
27. Matigian, N., Abrahamsen, G., Sutharsan, R., Cook, A. L., Vitale, A. M., Nouwens, A., Bellette, B., An, J., Anderson, M., Beckhouse, A. G. et al. (2010). Disease-specific, neurosphere-derived cells as models for brain disorders. Dis. Model. Mech. 3, 785-798.
28. Nguyen, T., Bjorkman, J., Paton, B. C. and Crane, D. I. (2006). Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance. J. Cell Sci. 119, 636-645.
29. Novarino, G., Fenstermaker, A. G., Zaki, M. S., Hofree, M., Silhavy, J. L., Heiberg, A. D., Abdellateef, M., Rosti, B., Scott, E., Mansour, L. et al. (2014). Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science (New York, NY) 343, 506-511.
30. Piperno, G., LeDizet, M. and Chang, X. J. (1987). Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J. Cell Biol. 104, 289-302.
31. Rapp, S., Saffrich, R., Anton, M., Jäkle, U., Ansorge, W., Gorgas, K. and Just, W. W. (1996). Microtubule-based peroxisome movement. J. Cell Sci. 109, 837-849.
32. Reed, N. A., Cai, D., Blasius, T. L., Jih, G. T., Meyhofer, E., Gaertig, J. and Verhey, K. J. (2006). Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol. 16, 2166-2172.
33. Riano, E., Martignoni, M., Mancuso, G., Cartelli, D., Crippa, F., Toldo, I., Siciliano, G., Di Bella, D., Taroni, F., Bassi, M. T. et al. (2009). Pleiotropic effects of spastin on neurite growth depending on expression levels. J. Neurochem. 108, 1277-1288.
34. Salinas, S., Proukakis, C., Crosby, A. and Warner, T. T. (2008). Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 7, 1127-1138.
35. Tarrade, A., Fassier, C., Courageot, S., Charvin, D., Vitte, J., Peris, L., Thorel, A., Mouisel, E., Fonknechten, N., Roblot, N. et al. (2006). A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum. Mol. Genet. 15, 3544-3558.
36. Wiemer, E. A., Wenzel, T., Deerinck, T. J., Ellisman, M. H. and Subramani, S. (1997). Visualization of the peroxisomal compartment in living mammalian cells: dynamic behavior and association with microtubules. J. Cell Biol. 136, 71-80.
37. Zhang, B., Carroll, J., Trojanowski, J. Q., Yao, Y., Iba, M., Potuzak, J. S., Hogan, A. M., Xie, S. X., Ballatore, C., Smith, A. B. and III et al. (2012). The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 32, 3601-3611.
38. Zhou, J., Gupta, K., Aggarwal, S., Aneja, R., Chandra, R., Panda, D. and Joshi, H. C. (2003). Brominated derivatives of noscapine are potent microtubuleinterfering agents that perturb mitosis and inhibit cell proliferation. Mol. Pharmacol. 63, 799-807.